Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Inhaled corticosteroid containing combinations and mortality in COPD.

Literature DB >> 30209195

Inhaled corticosteroid containing combinations and mortality in COPD.

Jørgen Vestbo^1,2, Leonardo Fabbri^3,4, Alberto Papi^3,5, Stefano Petruzzelli⁶, Mario Scuri⁶, Alessandro Guasconi⁶, Stefano Vezzoli⁶, Dave Singh^1,7.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2018 PMID： 30209195 DOI： 10.1183/13993003.01230-2018

Source DB: PubMed Journal: Eur Respir J ISSN： 0903-1936 Impact factor: 16.671

Keyword Cloud
Cited

× No keyword cloud information.

19 in total

1. Journal Club: Do Inhaled Corticosteroids Reduce All-Cause Mortality in Chronic Obstructive Pulmonary Disease? What is the Latest Evidence?

Authors: Ron Balkissoon
Journal: Chronic Obstr Pulm Dis Date: 2021-01

2. Use of Inhaled Corticosteroids and Risk of Acquiring Haemophilus influenzae in Patients with Chronic Obstructive Pulmonary Disease.

Authors: Raza Ul Mohsin; Christian Kjer Heerfordt; Josefin Eklöf; Pradeesh Sivapalan; Mohamad Isam Saeed; Truls Sylvan Ingebrigtsen; Susanne Dam Nielsen; Zitta Barrella Harboe; Kasper Karmark Iversen; Jette Bangsborg; Jens Otto Jarløv; Jonas Bredtoft Boel; Christian Østergaard Andersen; Henrik Pierre Calum; Ram B Dessau; Jens-Ulrik Stæhr Jensen
Journal: J Clin Med Date: 2022-06-20 Impact factor: 4.964

Review 3. Day and Night Control of COPD and Role of Pharmacotherapy: A Review.

Authors: Alberto Braghiroli; Fulvio Braido; Alessio Piraino; Paola Rogliani; Pierachille Santus; Nicola Scichilone
Journal: Int J Chron Obstruct Pulmon Dis Date: 2020-06-04

4. Management of the COPD Patient with Comorbidities: An Experts Recommendation Document.

Authors: Jesús Recio Iglesias; Jesús Díez-Manglano; Francisco López García; José Antonio Díaz Peromingo; Pere Almagro; José Manuel Varela Aguilar
Journal: Int J Chron Obstruct Pulmon Dis Date: 2020-05-07

5. Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease.

Authors: David A Lipson; Courtney Crim; Gerard J Criner; Nicola C Day; Mark T Dransfield; David M G Halpin; MeiLan K Han; C Elaine Jones; Sally Kilbride; Peter Lange; David A Lomas; Sally Lettis; Pamela Manchester; Neil Martin; Dawn Midwinter; Andrea Morris; Steven J Pascoe; Dave Singh; Robert A Wise; Fernando J Martinez
Journal: Am J Respir Crit Care Med Date: 2020-06-15 Impact factor: 21.405

Inhaled corticosteroid containing combinations and mortality in COPD.

1. Journal Club: Do Inhaled Corticosteroids Reduce All-Cause Mortality in Chronic Obstructive Pulmonary Disease? What is the Latest Evidence?

2. Use of Inhaled Corticosteroids and Risk of Acquiring Haemophilus influenzae in Patients with Chronic Obstructive Pulmonary Disease.

Review 3. Day and Night Control of COPD and Role of Pharmacotherapy: A Review.

4. Management of the COPD Patient with Comorbidities: An Experts Recommendation Document.

5. Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease.

6. The IMPACT of triple versus dual single-inhaler therapy on exacerbations of COPD.

Review 7. Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal.

8. Inhaled Corticosteroid Therapy in Bronchiectasis is Associated with All-Cause Mortality: A Prospective Cohort Study.

9. Fixed Triple Therapy in Chronic Obstructive Pulmonary Disease and Survival. Living Better, Longer, or Both?

10. Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis.